Biomarkers in Routine Heart Failure Clinical Care
Heart failure is a clinical condition with complex pathophysiology that involves many different processes. Diagnosis is often difficult in patients presenting for the first time with breathlessness. Many biomarkers have been identified that are elevated in heart failure and their role in assessing p...
Enregistré dans:
Auteurs principaux: | Sunil K Nadar, Muhammad Mujtaba Shaikh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/26939f98cb2b47ff85b9fdda0edab849 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time
par: Sunil K Nadar, et autres
Publié: (2019) -
Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure
par: Izabella Uchmanowicz, et autres
Publié: (2019) -
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
par: M Rizzo, et autres
Publié: (2020) -
Representation of Women Physicians in Heart Failure Clinical Practice
par: Ersilia M DeFilippis, et autres
Publié: (2021) -
The New Heart Failure Association Definition of Advanced Heart Failure
par: Marco Metra, et autres
Publié: (2019)